INTRODUCTION
Whole-body fractionated irradiation effectively induces thymic lymphomas in mice 1) . Malignant lymphoma cells are considered to develop through multi-step genetic events during latent periods after irradiation. Some of the genetic events, including nondisjunction with or without reduplication, heterozygous deletion, gene conversion and homologous or non-homologous mitotic recombination, can be detected as loss of heterozygosity (LOH) 2) . The LOH regions often harbor tumor-suppressor genes in numerous malignancies in both human and experimental animals 3, 4) . Therefore, the search for the tumor-suppressor genes responsible for tumorigenesis has centered on LOH studies to demonstrate the molecular genetic mechanism underlying the tumori-genesis. Analyses of allelotype in radiation-induced tumors from F 1 hybrid mice of inbred strains have been performed by several groups, because they are very simple and all tumors are uniformly informative at a number of loci as to the location of the tumor-suppressor gene regions.
Extensive allelotype analyses have substantially furthered our understanding of the molecular mechanism of radiation lymphomagenesis. Santos et al. (1996) suggested the existence of two tumor-suppressor gene regions, TLSR ( Thymic lymphoma suppressor region ) 1 between D4SWsm1 and D4Mit9 , and the more distal TLSR2, centered at the marker D4Mit54 , each homologous to the human chromosomal regions 9p21-22 and 1p32-36, respectively, in radiationinduced lymphomas of (C57BL/6J x RF/J) F 1 mice 5) . They also mapped a third region (TLSR3) within the area defined by Mom-1 and D4Mit68 6) , and found two additional tumor-suppressor gene loci at the proximalmid part of mouse chromosome 4 in T-cell lymphomas, defined by the markers D4Mit116 (TLSR4) and D4Mit21 (TLSR5). They then characterized a genomic DNA fragment of about 12 kb corresponding to the murine p73 gene, and reported evidence suggesting that p73 is the tumor-suppressor gene (TLSR2) around marker D4Mit205b at the distal end of chromosome 4 in T-cell lymphomas 7) . An extremely high frequency (more than 60%) of allelic loss on distal chromosome 12 was observed in radiation-induced lymphomas from (BALB/cHeA x MSM/Ms)F 1 [ (C x M)F 1 ] mice 8, 9) ; interestingly, this region is syntenic homologous to human chromosome 14q32-33. Frequent LOH at human chromosome 14q has been reported in a variety of tumors, such as neuroblastomas 10) , advanced colorectal carcinomas 11) , bladder cancers 12) , ovarian carcinomas 13, 14) , endometrial carcinomas 15) , and renal cell tumors 16) . Physical delineation of this region has shown that a putative tumor-suppressor gene exists within a 35 kb interval 17) and close to D12Mit233 18) . The Ikaros gene on centromeric chromosome 11 has been suggested to be an important tumor-suppressor gene in mouse thymic lymphomas 19, 20) . We also found frequent LOH on chromosome 19 with syntenic homology to human chromosomes 10q and 11p in addition to the LOH on chromosomes 4 and 12 in the lymphomas from (BALB/cHeA x STS/ A)F 1 [ (C x S)F 1 ] mice 21) . Santos et al . 22) described specific LOH on chromosome 19 in radiation-induced thymic lymphomas from (C57BL/6J x BALB/c)F1 mice, and evidence for a possible epigenetic mechanism.
In radiation-induced lymphomas, alterations of p53 are rare 23) . However, p53-deficient mice are extremely susceptible to the induction of lymphomas 24) . Although allelic loss at the centromeric , it is very rare in p53 +/+ mouse thymomas 8, 9, 21) , indicating that the LOH on chromosome 16 is specific to p53 KO/+ mice.
The evidence on the radiation-induced thymic lymphomas mentioned above indicates that the genome-wide patterns of LOH in F 1 mice differ with the parental combinations, even if the histopathological feature of the tumor and the oncogenic treatment are the same. This makes us suspect that different tumorsuppressor genes contribute to lymphomagenesis in different genetic backgrounds. Frequent LOH is observed on chromosomes 4, 12 and 19 in (CXS)F 1 mice, but only on chromosome 12 among (CXM) F 1 mice in which STS/A (S) and MSM/Ms (M) strains, respectively, are the parents. On the other hand, in (C57BL/6 X C3H/HeJ) F 1 (B6C3 F 1 ) mice, LOH (more than 20%) is observed on chromosomes 4, 11, 12, 15 and 19, and highly frequent allelic losses (about 50%) on chromosomes 11 and 12 19) . In this study, an allelotype analysis was performed in tumors from
] hybrid mice to examine the effects of the p53 status and genetic background on the genome-wide features of LOH.
MATERIALS AND METHODS

Mice
STS/A-p53 KO/+ mice were generated by backcrossing 129 p53 -deficient mice with STS/A mice ten times. STS/A-p53 KO/+ mice were crossed with MSM/ 
Ms mice to generate (S x M) F 1 and (S x M) F 1 -p53
KO/+ offspring. The conditions for breeding were described previously 8) .
Induction of thymic lymphomas
Mice were exposed four times to X-rays of 1.7Gy (0.5Gy/min) with weekly intervals starting at 4 weeks of age, and the moribund mice were examined as previously described 25) .
DNA isolation and LOH analysis
Developed lymphomas and normal tissues were removed. The isolation of DNA, PCR of microsatellite markers, electrophoresis of PCR products and assessment of allelic losses were performed according to a procedure described previously 8) . Oligonucleotide primers corresponding to microsatellite loci were purchased from Research Genetics, Inc. (Huntsville, AL). The chromosomal locations of the microsatellite markers and several loci were based on the 2000 Chromosome Committee Reports in the Mouse Genome Database (Mouse Genome Informatics; Jackson Laboratory, Bar Harbor, ME). Representative profiles for polyacrylamide gel electrophoresis of PCR products at microsatellite loci of DNA from normal and tumor tissues are shown in Fig. 1 .
RESULTS
Genome-wide search for LOH in thymic lymphomas from (S X M) F 1 -p53 KO/+ mice
A LOH analysis was first carried out for 24 thymic lymphomas from (S X M)F1-p53 KO/+ mice at 81 polymorphic microsatellite loci (Table 1 and Fig. 2 ). Table 1 gives the frequency of LOH at each locus. Highly frequent peaks were found at D12Mit233 (52 cM from centromere) to D12Mit263 (58 cM), D11Mit1 (0.25 cM) near Znfn1a1 (Ikaros), D11Mit4 (37 cM) near p53 and D16Mit74 (9.7 cM) to D16Mit4 (27.3 cM); the frequencies of LOH at these regions or loci were 67, 58, 50 and 33%, respectively. LOH with a lower incidence was also observed in several regions; four lymphomas out of 24 had LOH at The LOH frequencies markedly decreased at D11Mit1 (0.25 cM) and D11Mit7 (44.3 cM) compared with the p53 hetero-deficient (S X M) F 1 mice. The LOH on chromosome 16 also slightly decreased. In contrast, the incidence (5/20: 25%) of LOH at D4Mit54 (66 cM) in these (S X M) F 1 mice rather increased similar to that (2/24: 8%) in the lymphomas of (C X S) F 1 mice bearing wild-type p53, suggesting a reverse effect of p53 hetero-deficiency.
Allelotype analysis of the LOH regions in lymphomas from (S X M) F 1 -p53 KO/+ mice and (S X M) F 1 -p53 +/+ mice
To further examine the dependency of the frequency of LOH on the p53 status and the parental bias for the allelic loss, we determined allelotypes of more tumors in the regions on chromosomes 9, 12 and 19 in which LOH was observed at several loci encompassing wide areas. As shown in Table 3 , LOH on chromosome 9 was significantly more frequent in the p53 heterozygous-deficient mice in addition to the LOH on chromosome 11 mentioned above. Of 87 lymphomas, 14 (16%) showed LOH at D9Mit10 (49 cM) on chromosome 9 in the p53-deficient mice, while none of 24 lymphomas had allelic loss in wildtype mice. Although 123 tumors were examined at D19Mit80 (22 cM) in the p53 heterozygous-deficient mice, the incidence did not increase significantly compared with wild mice. Allelic loss at D12Mit233 (52 cM) was extremely high regardless of the p53 status. We compared the frequencies of the loss of the alleles derived from each parent in tumors. Preferential losses of STS-derived alleles on chromosome 9 and MSM-derived wild-type p53 alleles on chromosome 11 were found in (S x M)F 1 -p53 KO/+ mice.
Parental bias for lost alleles was not seen on chromosomes 12 and 19.
Comparison of the LOH frequency on chromosomes 4, 12 and 19 in F 1 -p53 +/+ mice with different parental backgrounds
The frequency of LOH on chromosomes 4, 12 and 19 in (S X M)F 1 hybrid mice (Table 2, Fig. 3 ) was compared with data described previously (Fig. 4) . Allelic loss on these three chromosomes in (C X S)F 1 hybrid mice was observed in 20 (27%), 42 (57%) and 37 (50%) of 74 lymphomas at D4Mit31 (51.3 cM), D12Mit17 (55 cM) and D19Mit11 (41 cM), respectively 21) . On the other hand, the frequency in (C X M)F 1 1 hybrid mice was 4 of 51 (8%), 83 of 125 (66%) and 2 of 25 (8%) at D4Mit13 (71 cM), D12Mit233 (52 cM) and D19Mit12 (35 cM), respectively 8) . Although the polymorphic markers used for each chromosome differed among the three F 1 hybrid mice, they were located quite near to each other. The frequency on chromosome 4 in (S X M)F 1 and (C X S)F 1 hybrid mice, one of the parents of which was STS/A, was high compared with that in (C X M)F 1 mice. In this region, alleles derived from the lymphoma-resistant STS/A strain are lost with a higher frequency than those from the susceptible strain BALB/cHeA in the (C X S)F 1 hybrid mice 21) . Loss of the STS/A-derived allele on chromosome 4 may predispose the animals to lymphomas. Therefore, tumor -suppressor gene(s) modifying resistance to radiation lymphomagenesis may reside on chromosome 4. The frequency on chromosome 19 in (C X S)F 1 hybrid mice was markedly high compared with that in (S X M)F 1 , and in (C X M)F 1 mice one of the parents of which was MSM/Ms. 
DISCUSSION
Malignant lymphomas are considered to develop through a multi-step genetic process and to be efficiently induced by genetic events brought about by irradiation. In an epidemiological study, few events are supposed to be directly involved in the leukemogenesis compared with those which occur in solid tumors 26) . To identify the genes involved in the development of leukemia/lymphoma, we studied radiation-induced lymphomas in mice. Also, to detect tumor-suppressor genes involved in the lymphomagenesis, we analyzed allelotypes in the tumors from F 1 hybrid mice.
The two hybrids, (S X M) F 1 -p53 KO/+ and (S X M) F 1 -p53
, used in this study, differed considerably in the latent period of lymphoma development. X-irradiated female (S X M) F 1 -p53 +/+ mice first developed thymic lymphomas about 4 months after the last irradiation, and thereafter the lymphomas were induced frequently from 6 to 10 months after the last irradiation (data not shown). The mean latent period of lymphoma development was 252±36 days (95% confidence interval by t-test). Incidences of the tumors reached 33% (20/60) at 1 year after the last irradiation.
On the other hand, in irradiated female (S X M) F 1 -p53 KO/+ mice, the lymphomas were first observed after about 3 months, and were induced most frequently from 3.5 to 7 months after the last irradiation (data not shown). The mean latent period was 147±12 days. The incidences of the tumors reached 32% (19/59) 1 year after the last irradiation. The p53 +/+ mice developed lymphomas about 3.5 months later than p53 KO/+ mice.
Thus, p53 heterozygous deficiency shortened the latent period of tumor development. The shortening of this period in (S x M)F 1 -p53 KO/+ mice might be mainly due to the highly frequent and preferential loss of MSM-derived wild-type p53 alleles (Table 3 ) as well as an increased incidence of LOH in several other regions (Table 1 and 2, Fig. 2 and 3 ). The frequency of LOH at D9Mit10 (49 cM) on chromosome 9 was significantly increased in the (S x M)F 1 -p53 KO/+ mice, and a preferential loss of STS/Aderived alleles at this locus was found. The STS/A mouse is extremely resistant to radiation lymphomagenesis 27) . We previously found STS/A-specific preferential allelic loss on chromosome 4 in (CXS) F 1 where the lymphoma resistance locus has been suggested to exist by analyzing CXS recombinant inbred strains 21) . A susceptibility locus for the lymphomagenesis was recently reported using the same BALB/ cHeA and STS/A mice 28) . An analysis of the underlying genes for susceptibility to ionizing radiation is relevant for radiation oncology 29) . The region lost around D9Mit10 might also contain gene(s) that modify the resistance to radiation lymphomagenesis. Pml (promyelocytic leukemia) and Mlh1 (mutL homolog 1) have been mapped near this region on chromosome 9. The fact that LOH on chromosome 9 increased in p53 heterozygous-deficient mice suggests that the loss of function of the putative tumor-suppressor gene on . LOH is reported around D9Mit355 (53 cM) and D16Mit57 (21.5 cM) in islet cell carcinomas arising in transgenic mice and referred to as Loh1 and Loh2, respectively 30) . It is also suggested that Loh1 contributes to the progression from the angiogenic stage to a solid tumor and that Loh2 contains an angiogenic suppressor. It is unclear whether Loh1 and Loh2 contain identical tumor-suppressor genes to our LOH regions.
The most frequent LOH on chromosome 12 occurred in all crosses tested, and has syntenic homology to human chromosome 14q32-33. LOH of 14q has been observed in a variety of human tumors such as neuroblastomas 10) , advanced colorectal carcinomas 11) , bladder cancers 12) , ovarian carcinomas 13, 14) , renal cell tumors 16) and endometrial carcinomas 15) . Recently, Kominami reported Rit1 coding a transcription factor, as a novel candidate for a tumor-suppressor gene at the common allelic loss region on the distal chromosome 12 of mice 31) . However, sequence information on the gene has not yet been released.
Twenty-nine (24%) of 123 lymphomas exhibited LOH at D19Mit80 (22 cM) on chromosome 19 in (S x M)F 1 -p53 KO/+ mice ( Table 3 ). The region was observed to encompass D19Mit80 (22 cM) to D19Mit71 (54 cM) ( Table 1 ). This wide area may contain more than one tumor-suppressor gene. Chromosome 19 is homologous to human chromosomes 10q23-q26, 9 and 11q11-q13. Human chromosome 10q23-q26 contains putative tumor-suppressor genes, such as PTEN /MMAC1 [32] [33] [34] [35] and MXI-1 36) . PTEN, a protein tyrosine phosphatase gene, of human chromosome 10q23.3, is mutated at a considerable frequency in brain, breast, and prostate cancer 32, 33) . Mutations and deletions of MMAC1 at chromosome 10q23.3 were observed in multiple advanced cancers, such as glioma, prostate, kidney and breast cancers 34) . Mice lacking Mxi1 (Mad) (10q24-q25) exhibit increased susceptibility to tumorigenesis either following a carcinogen treatment, or when also missing Ink4a 36) . Human chromosome 11q13 contains the multiple endocrine neoplasia type-1 (MEN1) gene, which is frequently mutated in familial MEN1 tumors and some sporadic endocrine tumors 37) . The LOH frequency on chromosome 19 was low in F 1 mice containing MSMderived genetic background (Fig. 4) . The reason is unknown.
